NCT06608017View on ClinicalTrials.gov

Study of Yupingfeng Powder Treating Allergic Rhinitis (AR)

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

October 31, 2025

Conditions
Allergic Rhinitis
Interventions
DRUG

Chinese Herbal Medicine granules

Treatment group

OTHER

Placebo

Placebo-controlled group

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT06608017 - Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) | Biotech Hunter | Biotech Hunter